(PinkSheets:VDRM),(Pinksheets:VDRM), LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, is pleased to announce the opening of a satellite office in Dubai to facilitate its ongoing expansion in the Middle East. Local regulations require businesses to maintain a physical office within […]

(NasdaqGM:CRMD), BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged with WSI PBG, a subsidiary of Golden State Medical Supply, to promote DefenCath(R) to healthcare providers in facilities operated by the

(NASDAQ:REPL), WOBURN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for patients with advanced

SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) — QuestionPro, a global leader in online survey and research services, has acquired the Happy Market Research Podcast (HMRP). With more than 480 episodes and 268,000 listens, the HMRP has become one of the most popular and influential market research industry podcasts. The podcast will now be called

(NASDAQ:PCRX), — Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer — — Key additions expected to support company's 5×30 path to becoming an innovative biopharmaceutical organization — PARSIPPANY, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid

(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr: ORN), MADRID, Spain and CAMBRIDGE, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, is pleased to announce the appointment of Dr. Pierre Beaurang as Strategy and Business Development Advisor.

(NYSE MKT:CVU), EDGEWOOD, N.Y., Jan. 21, 2025 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero(R)” or the “Company”) (NYSE American: CVU) announced that it has received several contracts totaling $4.3 Million for gunner window assemblies for the UH-60M Black Hawk(R) helicopter as part of a previously announced five-year, indefinite delivery indefinite quantity (IDIQ) contract. “CPI

(NASDAQ:BTM),(NASDAQ:BTMWW), ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, today announced certain preliminary financial results for the fourth quarter ended December 31, 2024. The Company expects revenue to range between $135 million and $137 million, compared to $135.3 million

(NasdaqGM:VSAT), CARLSBAD, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, announced today it was selected by NASA to support the agency's direct-to-Earth (DTE) capabilities via the Near Space Network (NSN) Services contract, part of a five-year multi-award indefinite delivery, indefinite quantity (IDIQ) contract program with an

(NasdaqGM:KROS),(NYSE:TAK),(TSE:4502.T), LEXINGTON, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ss”) family of proteins, today announced